Skip to content

Clinical trials

Phase 1 Metabolic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 1 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20065
20072
20091
20111
20131
20163
20172
20222
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Recruiting2
Not yet recruiting2
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Philip Kern2
University of Michigan2
University of Wisconsin, Madison2
Gary Van Guilder1
Massachusetts General Hospital1
Mayo Clinic1
Mclean Hospital1
Medical Life Care Planners, LLC1
Penn State University1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome23
Obesity7
Insulin Resistance5
Hypertension4
Prediabetic State4
Overweight3
Diabetes Mellitus2
Hyperglycemia2
Hyperlipidemias2
Weight Loss2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.